Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Haemophilus influenzae Type B Infections. According to GlobalData, Phase I drugs for Haemophilus influenzae Type B ...

Despite the success of Haemophilus influenzae type b vaccines ... At least half of invasive H influenzae infections are caused by nontypable strains. The spectrum of diseases includes sinusitis ...

Guillain-Barré Syndrome is an uncommon, rare neurological condition in which the immune system mistakenly attacks the body's ...

At first, much the same. But inevitably, dangerous diseases would resurge in a country that isn’t prepared for them.

In terms of its effectiveness in preventing deaths, our analysis of the data shows that influenza vaccination is able to ...

Haemophilus parasuis is a significant bacterial ... Recent research has focused on understanding the mechanisms of H. parasuis infections, the host's immune response, and the development of ...

Here's what bacterial meningitis is, how it's different from viral and other types of meningitis, and what treatment can be ...

Other common causes include Haemophilus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae. Antibiotic drugs, which treat bacterial infections, are the primary form of treatment for bacterial ...

Rhode Island Hospital at Brown University Health will receive $1 million to demonstrate proof of concept for a test that uses ...

If study treatment has to start earlier than 2 weeks post vaccination, prophylactic antibiotic treatment should be initiated. * If not previously vaccinated, vaccination against Haemophilus influenzae ...